Asthma

29 April 2010

Radio frequency device for asthma

The first device that uses radio frequency energy to help control lung inflammation in adults with severe chronic asthma has been approved by the US Food and Drug Administration.

0

The first device that uses radio frequency energy to help control lung inflammation in adults with severe chronic asthma has been approved by the US Food and Drug Administration.

The Alair Bronchial Thermoplasty System is designed for people 18 and older whose asthma isn't controlled with medication, including inhaled corticosteroids or long-acting beta agonists.

The device delivers radio frequency energy directly to the airways, heating and reducing the thickness of lung tissue and improving users' ability to breathe, the agency said in a news release.

To achieve the device's full benefit, users will require multiple sessions targeting different parts of the lungs.

How the device was tested

The device was evaluated in a clinical study involving 297 people with severe and persistent asthma. As a condition of approval, California-based manufacturer Asthmatx Inc. must conduct additional studies to evaluate the product's long-term safety and effectiveness, the FDA said.

Potential side effects include asthma attacks, wheezing, chest pain or tightness, partially collapsed lung, coughing up blood, anxiety, headache or nausea. The device should not be used by people with an implanted pacemaker or defibrillator, the agency said. - (HealthDay News, April 2010)

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Asthma Expert

Professor Keertan Dheda has received of several prestigious awards including the 2014 Oppenheimer Award, and has published over 160 peer-reviewed papers and holds 3 patents related to new TB diagnostic or infection control technologies. He serves on the editorial board of the journals PLoS One, the International Journal of Tuberculosis and Lung Disease, American Journal of Respiratory and Critical Medicine, Lancet Respiratory Diseases and Nature Scientific Reports, amongst others.Read his full biography at the University of Cape Town Lung Institute

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules